Corcept Therapeutics Inc (CORT)
50.07
+2.45
(+5.14%)
USD |
NASDAQ |
Nov 04, 16:00
50.07
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0691 |
| March 31, 2017 | 0.2039 |
| December 31, 2016 | 0.3544 |
| September 30, 2016 | 0.5993 |
| June 30, 2016 | 0.7232 |
| March 31, 2016 | 0.8093 |
| December 31, 2015 | 0.809 |
| September 30, 2015 | 1.002 |
| June 30, 2015 | 1.044 |
| March 31, 2015 | 1.008 |
| December 31, 2014 | -2.782 |
| September 30, 2014 | -6.576 |
| June 30, 2014 | 2.142 |
| March 31, 2014 | 0.7359 |
| December 31, 2013 | 0.2733 |
| September 30, 2013 | 0.1462 |
| June 30, 2013 | 0.0904 |
| March 31, 2013 | 0.0765 |
| December 31, 2012 | 0.0429 |
| September 30, 2012 | 0.4267 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| ADMA Biologics Inc | 0.6962 |
| Akebia Therapeutics Inc | -1.127 |
| Bioventus Inc | 2.539 |
| Alnylam Pharmaceuticals Inc | 31.64 |
| Catalyst Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 784.26M |
| Total Liabilities (Quarterly) | 145.42M |
| Shareholders Equity (Quarterly) | 638.84M |
| Current Ratio | 3.700 |